Omega Fund Management, LLC
- SEC CIK
- 0001637359
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 10
- 0 vs. Q1 2026
- Portfolio value
- $185.7M
- +$22.5M (+13.8%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BCAXBicara Therapeutics Inc. | COM | 1,822,150 | $54.1M | 29.1% | −570,000−23.8% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 8,081,089 | $45.9M | 24.7% | 00.0% | Unchanged | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 1,022,149 | $26.0M | 14.0% | 00.0% | Unchanged | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 3,289,661 | $25.1M | 13.5% | 00.0% | Unchanged | History |
| BBNXBeta Bionics, Inc. | COM | 1,316,183 | $20.6M | 11.1% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 241,255 | $6.79M | 3.7% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 843,750 | $2.94M | 1.6% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 455,361 | $2.69M | 1.4% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 876,357 | $1.52M | 0.8% | 00.0% | Unchanged | History |
| ODTXOdyssey Therapeutics, Inc. | COMMON STOCK | 2,893 | $54.1K | <0.1% | +2,893 | New | History |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are gone from this filing.